Diplomat acquires Burman’s Specialty Pharmacy
FLINT, Mich. — Diplomat Pharmacy announced Friday that it had acquired the Pennsylvania-based Burman’s Specialty Pharmacy for $72.8 million in cash and $10 million in Diplomat common stock. The acquisition has expanded Diplomat’s hepatitis C specialty services, as Burman’s individualized patient care is focused primarily on those with Hepatitis C.
“Burman's shares our strong commitment to patient care,” Diplomat CEO and chairman Phil Hagerman said. “We acquired Burman's to enhance our targeted clinical management programs, utilize its innovative hepatitis C technology platform and strong payer network, and increase our presence in the U.S. mid-Atlantic region.”
Burman’s uses HealthTrac software, which allows pharmacists and providers to collaborate more on patient care and can be especially helpful for patients with hepatitis C.
“Diplomat's patient-centric focus echoes our own approach,” Steve Burman, president and CEO of Burman’s said. “We pride ourselves on improving patient care with innovative technology. HealthTrac opens the lines of communication between all healthcare professionals involved to improve treatment efficiency in an effort to both improve results and reduce costs. Diplomat shares that vision and puts it into practice with high-touch patient care.”
“We believe the HealthTrac technology will significantly expand our hepatitis C services across our national footprint,” Hagerman said.
HRG’s Dave Wendland to present ‘Seven Deadly Sins of Community Pharmacy’ at McKesson ideaShare
WAUKESHA, Wis. — Dave Wendland, VP and member of the owners group at Hamacher Resource Group, will present a continuing education session, “Seven Deadly Sins of Community Pharmacy,” at the upcoming McKesson ideaShare 2015 conference.
The presentation, to be held June 25 from 1:30 p.m. to 3 p.m., will center on the most common challenges community pharmacies face trying to grow their front end.
Pharmacists attending will learn several key points during the session, including how to identify areas for improvement, key components essential for an effective front-end, and techniques to evaluate what is and isn’t working and how to enact change. The insights and recommendations are based on the hundreds of store visits and pharmacy assessment projects HRG has performed over the years.
HRG provides McKesson and its Health Mart pharmacies best practice solutions for the front of store.
“We’ve enjoyed a long-term strategic partnership with McKesson. Over the years, we’ve provided innovative category management tools for their independent pharmacies and have been asked to share our expertise via CE sessions at their annual conference. We are proud to be asked back to ideaShare this year and present a CE session to help pharmacists improve their front-end practices,” stated Tom Boyer, director of national accounts and member of the HRG owners group.
NACDS to Senate: Pharmacy can help improve chronic care for Medicare patients
ARLINGTON, Va. — Emphasizing the importance of quality and affordability, the National Association of Chain Drug Stores urged the Senate Committee on Finance Chronic Care Working Group to look to pharmacy in providing accessible, cost-effective preventive health services that can improve care for Medicare patients with chronic conditions.
This week, NACDS submitted a letter to the working group following a request for recommendations to improve chronic care for Medicare patients.
“Community pharmacies and pharmacists provide access to prescription medications and over-the-counter products, as well as cost-effective health services such as immunizations and disease screenings. Access to these types of services is especially vital for Medicare beneficiaries as nearly two-thirds are suffering from multiple chronic conditions,” NACDS wrote in the letter.
In its letter, NACDS stressed the importance of a team-based approach to treat chronic illness. With medications serving as the primary intervention of chronic disease and involved in 80 percent of all treatment regiments, it’s becoming even more critical for healthcare professionals to work together in the best interest of patients.
“A growing body of evidence suggests that when physicians, nurses, pharmacists and other healthcare professionals work collaboratively, better health outcomes are achieved,” NACDS wrote in its letter.
In addition, NACDS cited that the lack of pharmacist recognition as a provider by third-party payors, including Medicare, has limited the number and types of services pharmacists can provide, even though they are fully qualified to do so.
“The adoption of policies and legislation to increase access to much-needed services for underserved Americans, such as S. 314, the Pharmacy and Medically Underserved Areas Enhancement Act, would allow Medicare Part B to utilize pharmacists to their full capability by providing those underserved beneficiaries with services not currently reaching them,” NACDS stated in its letter.
NACDS also urged increased utilization of medication therapy management in Medicare Part D to help ensure access to services for patients with chronic conditions, such as diabetes, cardiovascular disease and high cholesterol. A number of studies have shown that MTM improves medication adherence and leads to better uses of medicines.
“We believe statutory changes should be made to revise the eligibility requirements so that beneficiaries with certain single chronic conditions will be eligible for MTM,” NACDS wrote.
“Through personal interactions with patients, face-to-face consultations and convenient access to preventive care services, local pharmacists are helping to shape the healthcare delivery system of tomorrow — in partnership with doctors, nurses, and others,” NACDS wrote.
Click here to read the entire letter.